Approved Abstracts

 

Download pdf

Full Abstracts

Abstract Title Section Code
Antimicrobial and chemical study of Fusarium fujikuroi isolated from Paepalanthus chiquitensis (Eriocaulaceae) Bioactive Natural Products BNP001
Evaluation of Miconia chamissois Naudin activity in vitro and in vivo on human glioma cell lines Bioactive Natural Products BNP002
Inhibitory action of the cerrado plants on gelatinase activity Bioactive Natural Products BNP003
The amazing antifungal activity of a sterol hydrazone analogue against the pathogenic fungus Sporothrix schenckii Bioactive Natural Products BNP004
Antimicrobial evaluation and Gas Chromatography-FID method development for the quantification of volatile compounds in Copaifera multijuga oleoresin Bioactive Natural Products BNP005
Antitumoral Effect of M. cuspidata on HeLa and 4T1 cell lines Bioactive Natural Products BNP006
In vitro determination of Sun Protection Factor (SPF) in extracts of Matricaria recutita L. Bioactive Natural Products BNP007
Identification, isolation and characterization of new antibacterial molecules from natural extracts Bioactive Natural Products BNP008
Identification of new anti-Trypanosoma cruzi agent from Baccharis articulata by NMR-based metabolomics profiling Bioactive Natural Products BNP009
Determination of Carboxymethyllysine, Pentosidine and Pyrraline using Ion Exchange Solid-Phase Extraction and LC-MS/ESI (Q-TOF) Clinical Pharmacology & Pharmacokinetics CPP001
Study of microsomal metabolism and chemical stability of LASSBio-1774: A novel anti-diabetes prototype Clinical Pharmacology & Pharmacokinetics CPP002
Pharmacokinetics and toxicological prediction of Neurokinin 1 (NK1) inhibitors Clinical Pharmacology & Pharmacokinetics CPP003
Plasmodium falciparum Enolase is a New Molecular Target for Antimalarial Discovery and Development Clinical Pharmacology & Pharmacokinetics CPP004
A direct Enzyme-Linked Immunosorbent Assay (ELISA) for the Quantitative Evaluation of Janus Kinase 3 (JAK3) Inhibitors Clinical Pharmacology & Pharmacokinetics CPP005
Profiling of epigenetic probes in gastric cancer cells Clinical Pharmacology & Pharmacokinetics CPP006
Cytotoxic effect, chemical and plasma stability and permeability profile of LASSBio-1920 Clinical Pharmacology & Pharmacokinetics CPP007
Evaluation of Trypanosoma cruzi activity and toxicity in Caenorhabditis elegans of a new series of 4-methylchloro coumarins Clinical Pharmacology & Pharmacokinetics CPP008
1000 Ways to inhibit TIMs Clinical Pharmacology & Pharmacokinetics CPP009
Combination of arilidenones for Chagas desease treatment: in vitro and in vivo estudies Arginine Pocket Clinical Pharmacology & Pharmacokinetics CPP010
Licarin A neolignan and ascorbic acid association in the treatment of experimental cutaneous leishmaniasis Clinical Pharmacology & Pharmacokinetics CPP011
LASSBio-1952 is a potent and selective inhibitor of HTLV-1– infected cells by arresting cell cycle and inducing apoptotic cell death Clinical Pharmacology & Pharmacokinetics CPP012
Novel Triazoles With Potent In vitro and In vivo Activity Against Trypanosoma cruzi Medicinal Chemistry and Drug Discovery MCD001
ECOFRIENDLY MICROWAVE ASSISTED SYNTHESIS OF SOME NACYLHYDRAZONES DERIVATIVES AND EVALUATION OF INHIBITION INTERACTION BETWEEN NUCLEIC ACIDS AND hnRN P K PROTEIN Medicinal Chemistry and Drug Discovery MCD002
Design and Synthesis of Curcumin-Cinnamaldehyde Hybrids as Cytotoxic Agents Against Lung Cancer Cells Medicinal Chemistry and Drug Discovery MCD003
Pyridine synthetic derivatives inspired in the alkaloid (-)-spectaline with antichagasic, antimalarial and leichmanicidal potential activities Medicinal Chemistry and Drug Discovery MCD004
Synthesis and evaluation of the antiproliferative activity of a new series of hybrid compounds based on the structures of curcumin and resveratrol Medicinal Chemistry and Drug Discovery MCD005
Synthesis and Evaluation of Antiprotozoal Activity of Gibbilimbol Derivatives Medicinal Chemistry and Drug Discovery MCD006
Synthesis and development of novel small molecules targeting Rac1 signaling as new potential leads for antitumor agents Medicinal Chemistry and Drug Discovery MCD007
Potential assessment anticholinesterase of thiazolidionones in cortex and hippocampus of rats Medicinal Chemistry and Drug Discovery MCD008
SYNTHESIS OF NEW INDENO[2,1-c]QUINOLINES BY CATIONIC IMINO DIELS-ALDER REACTION, COMPOUNDS WITH CYTOTOXIC ACTIVITY Medicinal Chemistry and Drug Discovery MCD009
Leishmanicidal activity and druglikeness profile of combretastatin A4 analogues Medicinal Chemistry and Drug Discovery MCD010
Synthesis, biological screening and reverse docking studies of phenylmethylidene benzohydrazides as antileishmanial compounds Medicinal Chemistry and Drug Discovery MCD011
Antiproliferative activity and chemical stability of novel N-acylhydrazones dual inhibitors of HDAC6/8 Medicinal Chemistry and Drug Discovery MCD012
Evaluation of hydroxymethylnitrofurazone (NFOH) in the chronic phase of Chagas’ disease in the animal model (Y strain – T. cruzi) Medicinal Chemistry and Drug Discovery MCD013
Discovery of new inhibitors of Schistosoma mansoni TGR by combining QSAR-based VS and biological assays Medicinal Chemistry and Drug Discovery MCD014
Synthesis of mesoionic compounds and investigation of their cytotoxic activity against cell lines infected by HTLV-1 Medicinal Chemistry and Drug Discovery MCD015
Bacillamides as Lead Compounds Against Dengue Virus NS5 and Human Metalloproteinase obtained by Virtual High-Throughput Screening (vHTS) Medicinal Chemistry and Drug Discovery MCD016
Synthesis and evaluation of epoxy-α-acylaminocarboxamides as cathepsin L inhibitors Medicinal Chemistry and Drug Discovery MCD017
Design, Synthesis via Click Chemistry and Antitripanosomal Activities of Novel Hybrids Analogues of Oryzalin and Tetrahydrofuran Neolignans Medicinal Chemistry and Drug Discovery MCD018
A new δ−valerolactam-benzimidazol hybrid anthelmintic derivative: synthesis and biological evaluation against Haemonchus contortus. Medicinal Chemistry and Drug Discovery MCD019
Combination of arylidenones for Chagas desease treatment: in vitro and in vivo estudies Medicinal Chemistry and Drug Discovery MCD020
Synthesis of natural and unnatural marinoquinolines analogues with potential application against tumor cell lineages Medicinal Chemistry and Drug Discovery MCD021
Biosynthesis of new curcumin glycoside potentially antioxidant and antifungal Medicinal Chemistry and Drug Discovery MCD022
Study on the role of acetylation on the cytotoxic activity of bis-1,4-naphthoquinones derivatives Medicinal Chemistry and Drug Discovery MCD023
SYNTHESIS OF CYCLOPEPTIDES BY SPPS AS POTENTIAL ANTIPARASITIC Medicinal Chemistry and Drug Discovery MCD024
Synthesis and evaluation of [1,2,4,5]tetrazine derivatives for 99mTc-bioorthogonal in vivo pretargeted imaging Medicinal Chemistry and Drug Discovery MCD025
Molecular design, synthesis and biological evaluation of novel dual inhibitors of VEGFR-2 and PDGFRβ Medicinal Chemistry and Drug Discovery MCD026
Synthesis and evaluation anti-Leishmania of new derivatives hybrids acridines-thiophenics Medicinal Chemistry and Drug Discovery MCD027
Synthesis of agarose derivatives with anticoagulant potential Medicinal Chemistry and Drug Discovery MCD028
Furoxan derivatives promote histone-H4 acetylation and induce fetal hemoglobin Medicinal Chemistry and Drug Discovery MCD029
Design, Synthesis and Antitubercular Activity of Novel Piperazine/Morpholine-Azachalcones Analogues Medicinal Chemistry and Drug Discovery MCD030
Synthesis of ligands and metal complexes with biological potential in the control strains of Candida albicans and Candida parapsilosis Medicinal Chemistry and Drug Discovery MCD031
a-ARYL-a-TETRALONES (1-CARBA-ISOFLAVANONES) AND 5-CARBA-PTEROCARPENS: NEW COMPOUNDS WITH POTENT ANTI-HCV ACTIVITY IN REPLICON REPORTER CELLS Medicinal Chemistry and Drug Discovery MCD032
Comparison of hydantoins and N(3)-substituted hydantoin derivatives in the enzymatic activity against acetylcholinesterase Medicinal Chemistry and Drug Discovery MCD033
2,4-Disubstituted Quinolines: Synthesis, Antifungal, Anticancer and Radical Scavenger Properties Medicinal Chemistry and Drug Discovery MCD034
Biosynthesis of novel anticancer N-oxides piperazines and their cytotoxic activities Medicinal Chemistry and Drug Discovery MCD035
Design, synthesis and evaluation of novel feruloyl-donepezil hybrids as potential multitarget drugs for the treatment of Alzheimer’s disease Medicinal Chemistry and Drug Discovery MCD036
Chalcone Derivatives as Potential Antituberculosis Agents: Design, Synthesis and Biological Activity Medicinal Chemistry and Drug Discovery MCD037
Design Conception, Synthesis, Leishmanicidal Activity, Druglikeness Profile and ADME Study of LASSBio-1736 Medicinal Chemistry and Drug Discovery MCD038
Development of new inhibitors of T. cruzi cruzain enzyme Medicinal Chemistry and Drug Discovery MCD039
Design, Synthesis and Anticancer Activity of Novel 1,2,3-triazole-aminoretinoid Lasquim 10 Medicinal Chemistry and Drug Discovery MCD040
Fragment screening against L,d transpeptidases from Mycobacterium tuberculosis Medicinal Chemistry and Drug Discovery MCD041
Synthesis and pharmacological evaluation of new imidazolones planned as cysteine proteases inhibitors for leukemia treatment Medicinal Chemistry and Drug Discovery MCD042
Development of hybrid fluorescent probes to study the biodistribution of anti-Trypanosoma cruzi agents Medicinal Chemistry and Drug Discovery MCD043
Bioisoster hybrids of N-acylhydrazone and furoxan groups: is cruzain the target for those potential anti-T. cruzi compounds? Medicinal Chemistry and Drug Discovery MCD044
Synthesis and biological evaluation of novel guanidine derivatives as leishmanicidal compounds Medicinal Chemistry and Drug Discovery MCD045
Potent in vivo leishmanicidal activity of N-oxide derivatives Medicinal Chemistry and Drug Discovery MCD046
Design, Synthesis and Anti-Trichomonas vaginalis Activity of Hydroxychalcones Medicinal Chemistry and Drug Discovery MCD047
Ultrasound promoted synthesis of thiazolidinones from 1-(2-aminoethyl)pyrrolidine and study of antimicrobial and cytotoxicity activities Medicinal Chemistry and Drug Discovery MCD048
Identification of N-(3-(3-phenylureido)quinoxalin-6-yl) acrilamides as a new scaffold for EGFR inhibition. Medicinal Chemistry and Drug Discovery MCD049
Acridone analogues with α-glucosidase Inhibitory Activity Medicinal Chemistry and Drug Discovery MCD050
ARTIMATNIB, a new hybrid salt as collateral sensitivity agent and its potential benefit in chronic myeloid leukemia patients Medicinal Chemistry and Drug Discovery MCD051
The anticholinesterase effect of 1,3-thiazolidin-4-ones Medicinal Chemistry and Drug Discovery MCD052
New hybrid 2-nitroimidazoles candidate antitrypanosomal agents Medicinal Chemistry and Drug Discovery MCD053
Synthesis of a novel potential AChE dual binding site inhibitor for Alzheimer’s disease treatment via Click Chemitry Medicinal Chemistry and Drug Discovery MCD054
Antibacterial activity of amino alcohols on resistant strains of Staphylococcus sp. Medicinal Chemistry and Drug Discovery MCD055
Synthesis of structural analogs of natural moroterpenes and evaluating the antitumour and antiparasitic potential Medicinal Chemistry and Drug Discovery MCD056
Synthesis of heterocyclic analogues of aripiprazole with potential antipsychotic activity Medicinal Chemistry and Drug Discovery MCD057
Determination of antiproliferative activity and possible mechanism of action of new spiro-acridines derivatives as potent drug to solid tumor Medicinal Chemistry and Drug Discovery MCD058
Bisthiazolidine heterocycles as metallo-beta-lactamase inhibitors Medicinal Chemistry and Drug Discovery MCD059
Fragment Based Drug Discovery (FBDD) in the Search of New Mycobacterium tuberculosis DHFR Inhibitors Medicinal Chemistry and Drug Discovery MCD060
Identification of novel kinase inhibitors of Plasmodium PK9 through structure-based virtual screening Medicinal Chemistry and Drug Discovery MCD061
OpenZika: an open science collaboration project to discover drug candidates against Zika virus Medicinal Chemistry and Drug Discovery MCD062
Ecofriendly microwave assisted synthesis of some N-acylhydrazones derivatives and evaluation of inhibition interaction between nucleic acids and hnRNP K protein Medicinal Chemistry and Drug Discovery MCD063
Inhibitory profile of thiazolidine-2,4-dione derivatives against Schistosoma mansoni dihydrofolate reductase Medicinal Chemistry and Drug Discovery MCD064
Synthesis and Immunosuppressive Activity of New Mycophenolic Acid Derivatives Medicinal Chemistry and Drug Discovery MCD065
Synthesis and Antibacterial Activity of 3’- and 4’- Aminochalcones Medicinal Chemistry and Drug Discovery MCD066
Tuberculostatic compounds: Structure-Based Drug Design and Synthesis of Maltosyltransferase GlgE inhibitors Medicinal Chemistry and Drug Discovery MCD067
Synthesis of 4-Chloromethylcoumarins and in vitro Antioxidant Evaluation Medicinal Chemistry and Drug Discovery MCD068
Synthesis of new bis-triazoles and antifungal evaluation against yeasts Sporothrix brasiliensis Medicinal Chemistry and Drug Discovery MCD069
Synthesis and evaluation of dihydrobenzofuran-piperazines as novel histamine receptor ligands Medicinal Chemistry and Drug Discovery MCD070
Phosphopantetheine adenylyltransferase potential inhibitors for the treatment of tuberculosis Medicinal Chemistry and Drug Discovery MCD071
Validation of Virtual Screening Protocol and Identification of a new GSK3β inhibitor: LASSBio-1806 Medicinal Chemistry and Drug Discovery MCD072
Optimization of Fragment Based Drug Discovery project to find New Leishmania donovani Nucleoside Hydrolase Inhibitor Medicinal Chemistry and Drug Discovery MCD073
Synthesis of analogues to Ciliatamide B and biological evaluation against pathogenic Trypanosomatids Medicinal Chemistry and Drug Discovery MCD074
SGC-UNICAMP: An Open Science Environment for Therapeutic Target Discovery and Validation Medicinal Chemistry and Drug Discovery MCD075
New Spiro-acridines as potent antitumoral agentes: Synthesis and RMN Medicinal Chemistry and Drug Discovery MCD076
Discovery of novel tetrahydro-naphthyl-N-acylhydrazones with in vivo anti-TNF-α effect and remarkable anti-inflammatory properties Medicinal Chemistry and Drug Discovery MCD077
Synthesis of Indololactones as selective RasGRP ligands Medicinal Chemistry and Drug Discovery MCD078
Synthesis of a new focused library of 4-methylamine coumarins and evaluation of the activity against Tripanosoma cruzi Medicinal Chemistry and Drug Discovery MCD079
Design and synthesis of novel diacylglycerol lipase α (DAGL- α) inhibitors for the treatment of obesity Medicinal Chemistry and Drug Discovery MCD080
Synthesis and antiproliferative evaluation of quinazoline derivatives on EGFR-overexpressing cell lines Medicinal Chemistry and Drug Discovery MCD081
Development of tool compounds to investigate the cellular function of human protein kinase VRK1 Medicinal Chemistry and Drug Discovery MCD082
Synthesis and pharmacological evaluation of new 4-hydroxy-methylpiperidinyl-N-benzyl- acylarylhydrazone derivatives planned as multi-target drug candidates against Alzheimer's disease Medicinal Chemistry and Drug Discovery MCD083
Recent challenges and advances in anti‐malarial drug discovery within the Unicamp‐MMV‐collaboration Medicinal Chemistry and Drug Discovery MCD084
Synthesis, anti-inflammatory in vivo and cytotoxicity in vitro studies of 2-aryl-3-(2-morpholinoethyl)thiazolidin-4-ones Medicinal Chemistry and Drug Discovery MCD085
Total synthesis and evaluation of tacrine-donepezil hybrid Medicinal Chemistry and Drug Discovery MCD086
Lung Cancer: EGFR Inhibitors with Low Nanomolar Activity against a Therapy-Resistant L858R/T790M/C797S Mutant Medicinal Chemistry and Drug Discovery MCD087
Looking for new anti-trypanosomatid agents from boron-containing compounds Medicinal Chemistry and Drug Discovery MCD088
Tuning Selectivity: Novel Covalent-Reversible JAK3-Inhibitors with High Isoform Specifity Targeting a Nitrile Induced Medicinal Chemistry and Drug Discovery MCD089
Reverse fosmidomycin analogues as potent 1-deoxy-D-xylulose 5-phosphate reductoisomerase inhibitors Medicinal Chemistry and Drug Discovery MCD090
LQB-118: a pterocarpanquinone with antileishmanial, anticancer and anti-inflammatory actions in mice Medicinal Chemistry and Drug Discovery MCD091
Synthesis and biological evaluation of furoxans derivatives against Leishmania amazonensis Medicinal Chemistry and Drug Discovery MCD092
Synthesis of 3,4-dihydropyrimidin-2-thiones N-1 substituted as potential kinesin-5 ligands Medicinal Chemistry and Drug Discovery MCD093
Aminochalcones as Myeloperoxidase Inhibitors: Design, Synthesis and Preliminary SAR Investigations Medicinal Chemistry and Drug Discovery MCD094
Study of natural and unnatural marinoquinolines as antimicrobial agents Medicinal Chemistry and Drug Discovery MCD095
New potencial Histone Deacetylase Inhibitors: in silico and in vitro cytotoxic evaluation Medicinal Chemistry and Drug Discovery MCD096
Citral Hydrazine-thiazole Derivative as Leishmanicidal Agent Medicinal Chemistry and Drug Discovery MCD097
On the tracks of endocannabinoids in C. elegans Medicinal Chemistry and Drug Discovery MCD098
Synthesis and in vitro pharmacological evaluation of novel aryl-piperazine derivatives designed as antipsychotic drug candidates Medicinal Chemistry and Drug Discovery MCD099
Synthesis and anti-Plasmodium falciparum activity of pyrazolopyrimidine-sulfonamides Medicinal Chemistry and Drug Discovery MCD100
Structural design, synthesis and evaluation of novel Hydrazone N-AcylHydrazones (HAH) as immunomodulators Medicinal Chemistry and Drug Discovery MCD101
Platinum(II)-chloroquine are multistage antimalarials against P. falciparum and P. vivax by impairing mitochondrial activity Medicinal Chemistry and Drug Discovery MCD102
Discovery of the First BpMP-I Metalloproteinase Inhibitors for the Treatment of Hemorrhage Caused by Snakebites Medicinal Chemistry and Drug Discovery MCD103
Molecular Dynamics Simulations of Zika Virus RNA Polymerase in Apo State and Complexed to the Active Metabolite of Sofosbuvir Molecular Modeling MMD001
Pharmacophore models towards dual inhibitors of Leishmania major Pteridine Reductase 1 and Dihydrofolate Reductase-Thymidylate Synthase Molecular Modeling MMD002
Oral Administration of Peptide-Based Drugs: Beyond Lipinski’s Rule Molecular Modeling MMD003
Identification of a novel putative inhibitor of the Plasmodium falciparum purine nucleoside phosphorylase: Exploring the purine salvage pathway to design new antimalarial drugs Molecular Modeling MMD004
Ligand and structure-based virtual screening to selection of potential ligands to the Anopheles gambiae Odorant Binding Protein 1 Molecular Modeling MMD005
Construction and validation of pharmacophore model for the Plasmodium falciparum dihydroorotate dehydrogenase inhibitors Molecular Modeling MMD006
Pharmacophore and docking-based hierarchical virtual screening to identify Plasmodium falciparum enoyl-ACP reductase inhibitors Molecular Modeling MMD007
In silico design of a conformational EGFR/VEGFR-2 chimera model for discovery of dual inhibitors of tyrosine kinases proteins Molecular Modeling MMD008
Quantum Chemical Analysis of molecular stability and reactivity of compounds for Bipolar Disorder treatment Molecular Modeling MMD009
Searching for potential human ecto-5’-nucleotidase (e5NT/CD73) inhibitors using different virtual screening approaches Molecular Modeling MMD010
Quantum Chemical study of GSK-3β inhibitors using Frontier Orbitals and MEP Molecular Modeling MMD011
A Molecular Docking Rationale for the Activity Profile of Natural Diarylheptanoids against Trypanosoma cruzi Molecular Modeling MMD012
In silico identification of potential inhibitors of Ribose 5-posphate isomerase of Trypanosoma cruzi Molecular Modeling MMD013
Design, Molecular Modelling and in-silico Physico-chemical and ADME Properties of New DPP-IV Inhibitors Molecular Modeling MMD014
Docking Studies for New Dihydropyrimidinethiones on Kinesin Eg5. Molecular Modeling MMD015
In silico design of novel A2A adenosine receptor (A2AAR) agonists Molecular Modeling MMD016
Identification of potential Leishmania infantum trypanothione reductase inhibitors by structure based virtual screening on natural and synthetic compound databases Molecular Modeling MMD017
Molecular modeling studies of potentially antichagasic and leishmanicidal dendrimer prodrugs Molecular Modeling MMD018
Quantum chemical study on chemical reactivity and molecular stability of acetylcholinesterase inhibitors Molecular Modeling MMD019
Phantom PAINS: Debunking the Myth about Pan-Assay Interference CompoundS. Molecular Modeling MMD020
Analysis of the frontier orbitals of acetylcholinesterase inhibitors molecules Molecular Modeling MMD021
A Structure-property relationship: theoretical and experimental evidence of a N∙∙∙S σ-hole intramolecular interaction in the cardioactive compound LASSBio-294 Molecular Modeling MMD022
A computational study of chemical reactivity and molecular stability of 6α, 7β-Diidroxivoucapan-17β-oic and derivatives with anticancer activity prostate Molecular Modeling MMD023
Prediction of biological activity and chemical accessibility on proposals molecules for treatment of chemical dependents on cannabis sativa l. Molecular Modeling MMD024
Contrasting structural alerts and QSAR-based predictions for skin sensitization Molecular Modeling MMD025
Molecular docking simulation to compounds isolated from species Drimys augustifolia and D. brasilienses with insecticidal properties Molecular Modeling MMD026
Evaluation of General and Specific Linear Scoring Functions for Virtual Screening Molecular Modeling MMD027
Virtual screening for the identification of novel Mycobacterium tuberculosis antigen 85C inhibitors Molecular Modeling MMD028
Pharmacophore modeling of beta-secretase (BACE1) inhibitors Molecular Modeling MMD029
A Leishmania infantum phosphatidylinositol 4-kinase model for the in silico screening of new inhibitors Molecular Modeling MMD030
Molecular Determinants of Selectivity at ALDH-2 isoenzyme Molecular Modeling MMD031
Molecular dynamics studies involving Trypanothione Reductase of Trypanosoma cruzi (TcTR) complexed with diaryl sulfides inhibitors Molecular Modeling MMD032
Data mining to find new potential inhibitors of endocannabinoid metabolism  Molecular Modeling MMD033
The Molecular Recognition of Methyltransferase Dengue virus: Implications for Biological Activity Molecular Modeling MMD034
Construction of the brazilian malaria molecular targets bank (BRAMMT) Molecular Modeling MMD035
An Application Scalable to Perform Virtual High-Throughput Screening (vHTS) for Multiple Compounds and Targets: Octopus Molecular Modeling MMD036
RunMopac: A Software for Ligand Refinement for Virtual Screening Molecular Modeling MMD037
Frontier orbital analysis of monoamine oxidase B inhibitors molecules Molecular Modeling MMD038
Synthesis and Biological Evaluation of Novel Selective Inhibitors of the Hydrolase O-GlcNAcase (OGA) Synthesis of Bioactive Compounds SBC001
Use of New Technologies for the Synthesis of Macrocyclic Peptides as Potential Agents against Malaria Synthesis of Bioactive Compounds SBC002
Sgc8-c-aptamer derivatives as molecular imaging agents: Optimization of preparation conditions Synthesis of Bioactive Compounds SBC003
Assessing an ultrasonic method for N-monoallylation of 4-chloroaniline: application of factorial design Synthesis of Bioactive Compounds SBC004
C–H activation reactions to decorate the pyridine moiety of furo[2,3-b]pyridine core Synthesis of Bioactive Compounds SBC005
Synthesis of N-benzyl-piperidinyl acyl-hydrazone derivatives as potential antiproliferative drug prototype candidates Synthesis of Bioactive Compounds SBC006
Towards the total synthesis of neofiscalin A, a potent antibacterial agent Synthesis of Bioactive Compounds SBC007
Synthesis of tyrphostins derivative using water/glycerol as catalyst Synthesis of Bioactive Compounds SBC008
Telescoped synthesis of heterocyclic building blocks based on 1,2,4-triazole-3-thiols Synthesis of Bioactive Compounds SBC009
Cardiovascular dendrimer prodrug derivative of acetylsalicylic acid and rosuvastatin: convergent synthesis Synthesis of Bioactive Compounds SBC010
Small-molecule kinase inhibitors-loaded boron cluster as hybrid agents for glioma cell-targeting therapy Synthesis of Bioactive Compounds SBC011
SYNTHESIS, FLUORESCENCE EMISSION AND UV RADIATION OF TRIAZINES DERIVATIVES Synthesis of Bioactive Compounds SBC012
Evaluation of antinociceptive activity of 3-hydroxy-piperidinyl-N-benzyl- acylarylhydrazone derivatives in phasic and neurophatic pain models Synthesis of Bioactive Compounds SBC013
In vitro one-step production of Olanzapine Phase I metabolites Synthesis of Bioactive Compounds SBC014
Synthesis and functionalization of promising heteroaromatic ring of the future for medicinal chemistry applications Synthesis of Bioactive Compounds SBC015
Synthesis of 3,3-diphenylcinnamyl alcohol, a versatile scaffold for the synthesis of bioactive compounds Synthesis of Bioactive Compounds SBC016
One-pot synthesis of antituberculosis compounds inspired on isoniazid Synthesis of Bioactive Compounds SBC017
Synthesis of dendrimeric prodrugs potentially active on neglected diseases Synthesis of Bioactive Compounds SBC018
MINIMALIST SCAFFOLD OF TRIAZOLYL-PRENYLATED COMPOUNDS: TOWARD NEW MODULATED ANTIPARASITIC AGENTS Synthesis of Bioactive Compounds SBC019
NITROARYLNITRONES WITH LEISHMANICIDAL ACTIVITY Synthesis of Bioactive Compounds SBC020

 

Download pdf

 Full Abstracts